Mexico

Mexico's pharmaceutical market comprised US$7.9bn worth of patented medicines and US$1.49bn worth of OTC drugs by the end of 2009. BMI believes that growth is still promising in the... 2010-02-09

The composition of the Mexican drug market is forecast to change over the next five years. While patented drugs will remain the dominant contributor to the market, with a large market... 2010-01-25

Mexico's state-run health insurance scheme for those on low incomes or without other healthcare options, Seguro Popular, is hoping to sign up an additional 12mn people in 2010, according... 2010-01-14

Healthcare spending in Mexico is expected to rise from MXN687bn (US$61.4bn) in 2008 to MXN961bn (US$92.6bn) by 2014, representing a compound annual growth rate (CAGR) of 5.4% in local... 2010-01-11

Brazilian pharmaceutical company Eurofarma has confirmed it is in negotiations to acquire companies in Uruguay, Paraguay and Colombia, reaffirming the company's intention to establish... 2010-01-08

The US Food and Drug Administration (FDA) has opened a new representative office in Mexico City, Mexico, the body's 3rd post in Latin America after Chile and Costa Rica. The presence... 2009-12-17

Mexican drugmaker Genomma Lab has announced that it intends to increase sales by up to 45% in 2010, chiefly through product diversification and global expansion. It has not alluded... 2009-12-16